Bot Chart, page-152

Hey thanks for posting that, very interesting read and educational. I'll have to read it a couple more times to fully digest it but the Conclusion was pretty good;

Concluding Thoughts
Although synthetically-derived processes have been around for numerous years, including their use by the pharmaceutical industry for well-known products such as Aspirin (acetylsalicylic acid) and insulin, we highlight this innovative field for its almost-certainly disruptive impact on the production of cannabinoids, to encourage investors to start familiarizing themselves with this technology and the relevant players. We view synthetically-derived cannabinoid businesses as key component to the overall supply chain within the cannabis industry. While much of the space is still somewhat early-stage, we believe that cannabis LP’s willbegin to pay much closer attention to these companies’ technology and its application to their industry, as it offers the potential for significant advantages on an operational and cost basis, as well as product quality and purity. We believe the possible synergies between the cannabis and synthetic biology/syntheticpharmaceutical spaces being unparalleled to either sector on its own.